Accueil>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>Dihydroartemisinin

Dihydroartemisinin (Synonyms: DHQHS 2, Dihydroqinghaosu)

Catalog No.GN10056

Dihydroartemisinin (DHA) is an active metabolite of artemisinin and its derivatives (ARTs) and is an effective drug widely used in the clinic to treat malaria.

Products are for research use only. Not for human use. We do not sell to patients.

Dihydroartemisinin Chemical Structure

Cas No.: 71939-50-9

Taille Prix Stock Qté
10mM (in 1mL DMSO)
46,00 $US
En stock
50mg
42,00 $US
En stock
100mg
63,00 $US
En stock
200mg
84,00 $US
En stock
500mg
147,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Dihydroartemisinin (DHA) is an active metabolite of artemisinin and its derivatives (ARTs) and is an effective drug widely used in the clinic to treat malaria[1]. Dihydroartemisinin exerts its anticancer effects through multiple molecular mechanisms, including inhibiting proliferation, inducing apoptosis, inhibiting tumor metastasis and angiogenesis, promoting immune function, inducing autophagy and endoplasmic reticulum stress[2]. Dihydroartemisinin can exert its cytotoxic effects through Fe(II)-mediated endoperoxide cleavage[3].

In vitro, Dihydroartemisinin (2.5-120μM) treated esophageal cancer cells (Eca109 and Ec9706 cells) for 48 and 72h, reducing cell viability in a dose-dependent manner, with IC50 values of 76.86μM and 93.81μM, respectively, and inducing cell apoptosis and cell cycle arrest[4]. Dihydroartemisinin (0-80µM) treatment of gastric cancer cells (SGC-7901, BGC823, and MGC803 cells) for 48 and 72h reduced cell viability in a dose-dependent manner and induced cell G1 arrest, apoptosis, and senescence[5].

In vivo, Dihydroartemisinin (20mg/kg) was intraperitoneally injected into mice inoculated with human hepatoma cells (HepG2) for 4 weeks, which significantly inhibited tumor growth and induced apoptosis of tumor tissue cells[6]. Dihydroartemisinin (20mg/kg) was intraperitoneally injected into colon cancer mice for 30 days, which significantly inhibited colon tumor formation, induced apoptosis of tumor tissue cells, and increased the expression of peroxisome proliferator-activated receptor γ (PPARγ)[7].

References:
[1] Zhang X G, Li G X, Zhao S S, et al. A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control[J]. Parasitology research, 2014, 113: 1769-1773.
[2] Dai X, Zhang X, Chen W, et al. Dihydroartemisinin: a potential natural anticancer drug[J]. International journal of biological sciences, 2021, 17(2): 603.
[3] Antoine T, Fisher N, Amewu R, et al. Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential[J]. Journal of antimicrobial chemotherapy, 2014, 69(4): 1005-1016.
[4] Du X X, Li Y J, Wu C L, et al. Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin[J]. Biomedicine & Pharmacotherapy, 2013, 67(5): 417-424.
[5] Sun H, Meng X, Han J, et al. Anti-cancer activity of DHA on gastric cancer—an in vitro and in vivo study[J]. Tumor Biology, 2013, 34: 3791-3800.
[6] Zhang C Z, Zhang H, Yun J, et al. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo[J]. Biochemical pharmacology, 2012, 83(9): 1278-1289.
[7] Lu Z, Peng J H, Zhang R, et al. Dihydroartemisinin inhibits colon cancer cell viability by inducing apoptosis through up-regulation of PPARγ expression[J]. Saudi journal of biological sciences, 2018, 25(2): 372-376.

Avis

Review for Dihydroartemisinin

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dihydroartemisinin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.